Genericon Pharma Gesellschaft m.b.H., Synthon B.V., Synthon Hispania S.L., Synthon s.r.o.

Poland

All drugs from this manufacturer

  • BEPLASOT

    The medicine is used in men to treat moderate or severe symptoms related to urination and bladder storage, caused by bladder problems and an enlarged prostate (benign prostatic hyperplasia). It is used when treatment with a single drug has not provided sufficient improvement.

    Dosage form: tablets, modified release

    Active substance Dosage
    solifenacin succinate 6 mg
    tamsulosin hydrochloride 0.4 mg

    ATC: G04CA53